Request Deal Involvement

Novartis to acquire Cadent Therapeutics for $770m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Argot Partners

pr advisors

Argot Partners

or

Principals

CADENT THERAPEUTICS

target

CADENT THERAPEUTICS

NOVARTIS AG

bidder

NOVARTIS AG

ATLAS VENTURE LP

vendor

ATLAS VENTURE LP

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

vendor

BLUE OWL HEALTHCARE OPPORTUNITIES (EX-COWEN HEALTHCARE INVESTMENTS)

QIMING VENTURE PARTNERS

vendor

QIMING VENTURE PARTNERS

SLATER TECHNOLOGY FUND

vendor

SLATER TECHNOLOGY FUND

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite